Claudio Festuccia
Overview
Explore the profile of Claudio Festuccia including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
125
Citations
2130
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mancini A, Colapietro A, Cristiano L, Rossetti A, Mattei V, Gravina G, et al.
Front Oncol
. 2025 Feb;
15:1538834.
PMID: 39911630
[This corrects the article DOI: 10.3389/fonc.2022.943064.].
2.
Gravina G, Marampon F, Giusti I, Carosa E, Di Sante S, Ricevuto E, et al.
Int J Oncol
. 2025 Jan;
66(2.
PMID: 39749699
Following the publication of the above article, a concerned reader drew to the Editor's attention that certain of the western blot assay data shown in Fig. 4G on p. 717...
3.
Gravina G, Colapietro A, Mancini A, Rossetti A, Martellucci S, Ventura L, et al.
Cancers (Basel)
. 2024 Aug;
16(16).
PMID: 39199697
In the original publication [...].
4.
Camero S, Milazzo L, Vulcano F, Ceccarelli F, Pontecorvi P, Pedini F, et al.
BMC Cancer
. 2024 Jul;
24(1):814.
PMID: 38977944
Background: Despite a multimodal approach including surgery, chemo- and radiotherapy, the 5-year event-free survival rate for rhabdomyosarcoma (RMS), the most common soft tissue sarcoma in childhood, remains very poor for...
5.
Rossetti A, Chonco L, Alegria N, Zelli V, Garcia A, Ramirez-Castillejo C, et al.
Pharmaceutics
. 2024 May;
16(5).
PMID: 38794272
Deer antlers are the fastest growing tissue. Because they are based on proto-oncogenes, to avoid the risk of cancer, antlers evolved strong anticancer mechanisms, and thus their extract (DVA) is...
6.
Festuccia C, Corrado M, Rossetti A, Castelli R, Lodola A, Gravina G, et al.
Pharmaceuticals (Basel)
. 2023 Oct;
16(10).
PMID: 37895923
The Eph kinases are the largest receptor tyrosine kinases (RTKs) family in humans. PC3 human prostate adenocarcinoma cells are a well-established model for studying Eph-ephrin pharmacology as they naturally express...
7.
Vaccaro S, Rossetti A, Porrazzo A, Camero S, Cassandri M, Pomella S, et al.
Front Pharmacol
. 2022 Dec;
13:1071176.
PMID: 36532747
Treatment of rhabdomyosarcoma (RMS), the most common a soft tissue sarcoma in childhood, provides intensive multimodal therapy, with radiotherapy (RT) playing a critical role for local tumor control. However, since...
8.
Mancini A, Colapietro A, Cristiano L, Rossetti A, Mattei V, Gravina G, et al.
Front Oncol
. 2022 Nov;
12:943064.
PMID: 36408162
Background: Glioblastoma multiforme (GBM) is the most malignant adult brain tumor. Current standard of care treatments have very limited efficacy, being the patients´ overall survival 14 months and the 2-year...
9.
Petricca S, Celenza G, Luzi C, Cinque B, Lizzi A, Franceschini N, et al.
Int J Mol Sci
. 2022 May;
23(10).
PMID: 35628239
Triazole and imidazole fungicides represent an emerging class of pollutants with endocrine-disrupting properties. Concerning mammalian reproduction, a possible causative role of antifungal compounds in inducing toxicity has been reported, although...
10.
Colapietro A, Yang P, Rossetti A, Mancini A, Vitale F, Chakraborty S, et al.
Front Pharmacol
. 2022 Apr;
13:852941.
PMID: 35401175
Glioblastoma multiforme (GBM) is the most common as well as one of the most malignant types of brain cancer. Despite progress in development of novel therapies for the treatment of...